FDA Inspection
Steris PLCSteris PLC – FDA Inspection, Nov 6, 2023
Record Details
This FDA Inspection record concerns Steris PLC, with an inspection on November 6, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Jill J. Tillman (Issuing Officer)
- Monica E. Murie (Investigator)
View Company Profile
ID · be8a0958-950e-4a2c-97b4-074ab65e93be
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1223087
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Steris PLC
4| Date | Classification | Office | Project area |
|---|---|---|---|
| June 8, 2016 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| February 27, 2015 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| May 17, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 16, 2009 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
Other documents for Steris PLC
- FDA Inspection 977303 - 2016-06-08
- FDA Inspection 915094 - 2015-02-27
- FDA Inspection 724872 - 2011-05-17
- FDA Inspection 599535 - 2009-07-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.